Inventor · disambiguated record
Rajeshwar Reddy Sagyam
Also filed as: SAGYAM RAJESHWAR R · SAGYAM RAJESHWAR REDDY
10 granted patents·12 pending applications·27 citations·filing 2005–2023
82Inventor score
Files withMSN LABORATORIES PRIVATE LTD R&D CENTER11MSN LABORATORIES PRIVATE LTD2BOLUGODDU VIJAYA B1GUDIPATI SRINIVASULU1KATKAM SRINIVAS1
Top patents by PatentIndex Score
22 records- 0188US11261160B2Process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (2S)-hydroxybutanedioate and its polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2017·Granted Mar 1, 2022·9 cites·15 claims
- 0282US7161004B2Processes to produce intermediates for rosuvastatinREDDYS LAB INC DR·Filed 2005·Granted Jan 9, 2007·8 cites·10 claims
- 0376US8779161B2Asenapine maleateKATKAM SRINIVAS·Filed 2011·Granted Jul 15, 2014·10 cites·21 claims
- 0460US2025074912A1Improved process for the preparation of upadacitinibMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2023·Application pending·0 cites
- 0559US2025136602A1Process for the preparation of a pure amorphous form of ubrogepantMSN LABORATORIES PRIVATE LTD F&D CENTER·Filed 2022·Application pending·0 cites
- 0658US2024327352A1Novel process for the preparation of 1-(2-{4-[(4-carbamoylpiperidin-1-yl)methyl]- n-methylbenzamido}ethyl)piperidin-4-yl n-({1,1'-biphenyl}-2-yl)carbamateMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 0754US12227506B2Crystalline polymorphs of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Feb 18, 2025·0 cites·12 claims
- 0852US12473292B2Polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Nov 18, 2025·0 cites·7 claims
- 0952US11149026B2Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride and their processes for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Granted Oct 19, 2021·0 cites·13 claims
- 1052US2024300930A1Novel process for the preparation of 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxideMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2022·Application pending·0 cites
- 1150US11236050B2Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Granted Feb 1, 2022·0 cites·12 claims
- 1249US2022315605A1IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OFSRINIVASAN THIRUMALAI RAJAN·Filed 2020·Application pending·0 cites
- 1346US12227518B2Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido [1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Granted Feb 18, 2025·0 cites·16 claims
- 1446US2020306225A1Stable n-((1r,2r)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl) octanamide (2r,3r)-2,3-dihydroxysuccinate premix and process for preparation thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2018·Application pending·0 cites
- 1546US2022251052A1Improved process for the preparation of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid or its pharmaceutically acceptable salts and polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2020·Application pending·0 cites
- 1640US10913762B2Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Feb 9, 2021·0 cites·17 claims
- 1737US2006009640A1Preparation of (-)-galantamine hydrobromideBOLUGODDU VIJAYA B·Filed 2005·Application pending·0 cites
- 1836US2011213150A1Preparation of crystalline palonosetron hydrochlorideREDDYS LAB LTD DR·Filed 2011·Application pending·0 cites
- 1933US10703731B2Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Jul 7, 2020·0 cites·12 claims
- 2033US2007117996A1Process for preparing simvastatinGUDIPATI SRINIVASULU·Filed 2006·Application pending·0 cites
- 2132US2020017483A1A process for the preparation of d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4- [[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, ( 1 s)THIRUMALAI RAJAN SRINIVASAN·Filed 2018·Application pending·0 cites
- 2231US2019177281A1Process for the preparation of 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino] methyl-2-methoxybenzoic acid and its polymorphs thereofTHIRUMALAI RAJAN SROMOVASAM·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajeshwar Reddy Sagyam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →